Too Old to Operate11h
Adjuvant durvalumab therapy improves survival in limited-stage small cell lung cancer
In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...
Can Deep Breathing Exercises Prevent Lung Cancer? Here's What The Expert Says
One of the most distressing symptoms of lung issues, including the dreaded cancer, is shortness of breath, also known as ...
Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA
Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for ...
Ohio State licenses cancer drug with 'tremendous potential' invented at the James
An experimental drug starting clinical trials next month at Ohio State University's James Cancer Hospital represents a first ...
Business Insider11h
Biotech Alert: Searches spiking for these stocks today
Tumor types treated to date include breast, colon, pancreatic and non-small cell lung cancer. Positive preliminary data from the study were presented at the European Society of Medical Oncology ...
Targeted Oncology21h
Future Treatment Landscape for EGFR-mutated Non-Small Cell Lung Cancer
Panelist discusses how the future treatment landscape for EGFR-mutant advanced non–small cell lung cancer is evolving to address current unmet needs and offers clinical pearls to community oncologists ...